• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by SI-BONE Inc.

    11/8/24 12:14:44 PM ET
    $SIBN
    Medical/Dental Instruments
    Health Care
    Get the next $SIBN alert in real time by email
    SC 13G 1 si-boneinc13g.htm SC 13G Document

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

    SCHEDULE 13G
    Under the Securities Exchange Act of 1934
    (Amendment No. ) *

    SI-BONE, INC.
    (Name of Issuer)


    COMMON STOCK
    (Title of Class of Securities)

    825704109
    (CUSIP Number)

    SEPTEMBER 30, 2024
    (Date of Event Which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    X    Rule 13d-1(b)
    ☐    Rule 13d-1(c)
    ☐    Rule 13d-1(d)
    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


    image_5a.jpg


    Page 1 of 8 Pages



    image_5a.jpgCUSIP No. 825704109
    1.Names of Reporting Persons
    American Century Investment Management, Inc.
    image_5a.jpg
    2.Check the Appropriate Box if a Member of a Group (See Instructions)
    a)☐
    b)☐
    image_5a.jpg
    3.SEC Use Only

    image_5a.jpg
    4.Citizenship or Place of Organization
    Delaware
     
    5.

    Sole Voting Power

    1,979,040
    Number of Shares
    Beneficially

    6.
     
    Shared Voting Power

     N/A
    Owned by  
    Each
    Reporting
    Person With:

    7.
     
    Sole Dispositive Power

    2,141,901
     
    8.
     
    Shared Dispositive Power

    N/A

    9.

    Aggregate Amount Beneficially Owned by Each Reporting Person

    2,141,901

    10.

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares
    (See Instructions) ☐
     
           11.

    Percent of Class Represented by Amount in Row (9)

    5.14%

    12.

    Type of Reporting Person (See Instructions)

    IA



    Page 2 of 8 Pages



    image_5a.jpgCUSIP No. 825704109
    1.Names of Reporting Persons
    American Century Companies, Inc.
    image_5a.jpg
    2.Check the Appropriate Box if a Member of a Group (See Instructions)
    a)☐
    b)☐
    image_5a.jpg
    3.SEC Use Only

    image_5a.jpg
    4.Citizenship or Place of Organization
    Delaware
     
    5.

    Sole Voting Power
    1,979,040
    Number of Shares
    Beneficially

    6.
     
    Shared Voting Power

     N/A
    Owned by  
    Each
    Reporting
    Person With:

    7.
     
    Sole Dispositive Power

    2,141,901
     
    8.
     
    Shared Dispositive Power

    N/A

    9.

    Aggregate Amount Beneficially Owned by Each Reporting Person

    2,141,901

    10.

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares
    (See Instructions) ☐

    11.

    Percent of Class Represented by Amount in Row (9)

    5.14%

    12.

    Type of Reporting Person (See Instructions)

    HC



    Page 3 of 8 Pages



    image_5a.jpgCUSIP No. 825704109
    1.Names of Reporting Persons
    Stowers Institute for Medical Research
    image_5a.jpg
    2.Check the Appropriate Box if a Member of a Group (See Instructions)
    a)☐
    b)☐
    image_5a.jpg
    3.SEC Use Only

    image_5a.jpg
    4.Citizenship or Place of Organization
    Delaware
     
    5.

    Sole Voting Power
    1,979,040
    Number of Shares
    Beneficially

    6.
     
    Shared Voting Power

     N/A
    Owned by  
    Each
    Reporting
    Person With:

    7.
     
    Sole Dispositive Power

    2,141,901
     
    8.
     
    Shared Dispositive Power

    N/A

    9.

    Aggregate Amount Beneficially Owned by Each Reporting Person

    2,141,901

    10.

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares
    (See Instructions) ☐

    11.

    Percent of Class Represented by Amount in Row (9)

    5.14%

    12.

    Type of Reporting Person (See Instructions)

    HC



    Page 4 of 8 Pages



    Item 1.
    a)Name of Issuer

    Si-Bone, Inc.

    b)Address of Issuer’s Principal Executive Offices

    471 El Camino Real, Suite 101
    Santa Clara, California 95050
    Item 2.
    a)Name of Person Filing:
    1)American Century Investment Management, Inc.
    2)American Century Companies, Inc.
    3)Stowers Institute for Medical Research

    a)Address of Principal Business Office or, if none, Residence.
    4500 Main Street
    9th Floor
    Kansas City, Missouri 64111

    c)Citizenship.
    1)Delaware
    2)Delaware
    3)Delaware

    d)Title of Class of Securities
    Reference is made to the cover page of this filing.

    e)CUSIP Number.
    Reference is made to the cover page of this filing.




    Page 5 of 8 Pages



    Item 3.    If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    1)American Century Investment Management, Inc. is an investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).
    2)American Century Companies, Inc. is a parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
    3)Stowers Institute for Medical Research is a parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).

    Item 4.     Ownership.
         Reference is made to Items 5-9 and 11 on the cover page of this filing.
    Item 5. Ownership of Five Percent or Less of a Class.
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [ ]
    Item 6. Ownership of More than Five Percent on Behalf of Another Person.
    Various persons, including the investment companies and separate institutional investor accounts that American Century Investment Management, Inc. (“ACIM”) serves as investment adviser, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities that are the subject of this schedule.  Except as may be otherwise indicated if this is a joint filing, not more than 5% of the class of securities that is the subject of this schedule is owned by any one client advised by ACIM.
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
    See attached Exhibit A.
    Item 8. Identification and Classification of Members of the Group.
    Not applicable.
    Item 9. Notice of Dissolution of Group
    Not applicable






    Page 6 of 8 Pages



    Item 10. Certification
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

    SIGNATURE
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated this 8th day of November, 2024.

    AMERICAN CENTURY INVESTMENT MANAGEMENT, INC. (“ACIM”)

    AMERICAN CENTURY COMPANIES, INC. (“ACC”)

    By:     __/s/ John Pak______________
        John Pak
        Senior Vice President, ACIM and ACC
        

    STOWERS INSTITUTE FOR MEDICAL RESEARCH, solely in its capacity as control entity of ACC

    By:    __/s/ Richard W. Brown_______
        Richard W. Brown
        Chairman

    SCHEDULE 13G – To be included in statements filed pursuant to Rule 13d-1(b) or 13d-2(b).

    EXHIBIT A
    This Exhibit has been prepared to identify each subsidiary of American Century Companies, Inc. (“ACC”), which is controlled by the Stowers Institute for Medical Research, that is a beneficial owner of securities that are the subject of this schedule (the “Subject Securities”).  American Century Investment Management, Inc. (“ACIM”) is a wholly-owned subsidiary of ACC and an investment adviser registered under §203 of the Investment Advisers Act of 1940.
    SCHEDULE 13G – To be included in statements filed pursuant to Rule 13d-1(b) or 13d-2(b) and Rule 13d-1(f) (1) Agreement.




    Page 7 of 8 Pages



    EXHIBIT B
    Each of the undersigned hereby agrees and consents to the execution and joint filing on its behalf by American Century Investment Management, Inc. of this Schedule 13G respecting the beneficial ownership of the securities which are the subject of this schedule.

    Dated this 8th day of November, 2024.

    AMERICAN CENTURY INVESTMENT MANAGEMENT, INC. (“ACIM”)

    AMERICAN CENTURY COMPANIES, INC. (“ACC”)

    By:     __/s/ John Pak______________
        John Pak
        Senior Vice President, ACIM and ACC
        

    STOWERS INSTITUTE FOR MEDICAL RESEARCH, solely in its capacity as control entity of ACC

    By:    __/s/ Richard W. Brown_______
        Richard W. Brown
        Chairman











    Page 8 of 8 Pages

    Get the next $SIBN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SIBN

    DatePrice TargetRatingAnalyst
    8/6/2024$27.00 → $19.00Buy
    Needham
    3/28/2024$25.00Overweight
    Piper Sandler
    10/12/2022$20.00Buy
    Jefferies
    4/7/2022$34.00Overweight
    Cantor Fitzgerald
    3/1/2022$30.00 → $28.00Overweight
    Morgan Stanley
    1/18/2022$43.00 → $36.00Buy
    B of A Securities
    12/21/2021$35.00 → $30.00Buy
    Truist Securities
    11/9/2021$42.00 → $36.00Market Outperform
    JMP Securities
    More analyst ratings

    $SIBN
    Financials

    Live finance-specific insights

    See more
    • SI-BONE To Present at BofA Securities 2025 Healthcare Conference on May 13, 2025

      SANTA CLARA, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming 2025 BofA Securities Healthcare Conference in Las Vegas. Management will be hosting a fireside chat on Tuesday, May 13, 2025, at 8:40 a.m. Pacific Time/11:40 a.m. Eastern Time. Investors interested in listening to the conference call may do so by registering at this link: https://bofa.veracast.com/webcasts/bofa/healthcare2025/id92Nrrn.cfm. Live audio of the webcast will be available on the "Investors" section of the company's website at: www.si-bone.com. The webcast wil

      5/6/25 4:09:00 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • SI-BONE, Inc. Reports Financial Results for the First Quarter 2025 and Updates 2025 Guidance

      First Quarter 2025 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $47.3 million, representing growth of 24.9%U.S. revenue of $44.8 million, representing growth of 26.6%Gross margin of 79.7%, representing an improvement of 80 basis pointsNet loss of $6.5 million, representing an improvement of 40.0%Positive adjusted EBITDA of $0.5 million$144.4 million in cash and equivalents, with net cash usage in the quarter declining 31.7% to $5.6 million Recent Operational Highlights (any comparisons are to the prior year period) Over 1,400 active U.S. physicians with 300 physicians

      5/5/25 4:09:00 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • SI-BONE To Report First Quarter 2025 Financial Results on May 5, 2025

      SANTA CLARA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the first quarter of 2025 after market close on Monday, May 5, 2025. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by registering at this link: https://edge.media-server.com/mmc/p/ueassh6s. Live audio of the webcast will be available on the "Investors" section of the company's website at: www.si-bone.com. The webcast will be archived and available for replay for a

      4/14/25 4:09:00 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care

    $SIBN
    Leadership Updates

    Live Leadership Updates

    See more
    • Bruker Appoints Laura Francis to its Board of Directors

      Bruker Corporation (NASDAQ:BRKR) today announced that its Board of Directors has appointed Laura Francis to serve on its board as an independent director, effective as of February 18, 2025. Ms. Francis is also expected to join Bruker's Audit Committee as a financial expert after Bruker's annual shareholder meeting at the end of May 2025. Laura Francis is the Chief Executive Officer and a Board Member of SI-BONE, Inc. (NASDAQ:SIBN), a medical device company solving musculoskeletal disorders of the sacropelvic anatomy. She was previously the Chief Financial Officer and Chief Operating Officer of the company. Prior to joining SI-BONE, Ms. Francis held other executive and leadership roles with

      2/21/25 8:00:00 AM ET
      $BRKR
      $PGNY
      $SIBN
      $SWAV
      Biotechnology: Laboratory Analytical Instruments
      Industrials
      Misc Health and Biotechnology Services
      Health Care
    • Mainstay Medical Announces Appointment of Jeffrey Dunn and Eric Major to its Board of Directors

      Mainstay Medical Holdings plc today announced the appointment of two new independent members to the company's board of directors, Jeffrey Dunn and Eric Major. These appointments bring Mainstay's total board membership to seven. "We are pleased to welcome these two transformational business leaders as new independent directors on the Board," said David Brabazon, Chairman of the Mainstay Board of Directors. "Their deep experience will be invaluable to Mainstay as we grow our business and pursue our mission to serve patients with intractable chronic low back pain." "As our business evolves and we continue to focus on commercial growth, broadening the industry expertise on our Board will help

      12/14/21 8:00:00 AM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • SI-BONE Appoints Anshul Maheshwari as Chief Financial Officer and Announces the Addition of Helen Loh and Laura Francis to the Board of Directors

      SANTA CLARA, Calif., April 19, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (NASDAQ:SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced the appointment of Anshul Maheshwari as the company's Chief Financial Officer effective April 20, 2021, and the addition of Helen Loh and Laura Francis to its Board of Directors effective April 18, 2021. The appointment of Mr. Maheshwari completes the recently announced senior leadership transition which includes Laura Francis succeeding Jeff Dunn as Chief Executive Officer, and Tony Recupero becoming President, Commercial Operations. Jeff Dunn will remain with the compa

      4/19/21 7:00:49 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care

    $SIBN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Needham reiterated coverage on SI-BONE with a new price target

      Needham reiterated coverage of SI-BONE with a rating of Buy and set a new price target of $19.00 from $27.00 previously

      8/6/24 8:40:50 AM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • Piper Sandler initiated coverage on SI-BONE with a new price target

      Piper Sandler initiated coverage of SI-BONE with a rating of Overweight and set a new price target of $25.00

      3/28/24 7:47:33 AM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • Jefferies initiated coverage on SI-BONE with a new price target

      Jefferies initiated coverage of SI-BONE with a rating of Buy and set a new price target of $20.00

      10/12/22 9:04:16 AM ET
      $SIBN
      Medical/Dental Instruments
      Health Care

    $SIBN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $SIBN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Amendment: SEC Form SC 13G/A filed by SI-BONE Inc.

      SC 13G/A - SI-BONE, Inc. (0001459839) (Subject)

      11/14/24 6:27:27 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by SI-BONE Inc.

      SC 13G - SI-BONE, Inc. (0001459839) (Subject)

      11/14/24 4:43:38 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by SI-BONE Inc.

      SC 13G - SI-BONE, Inc. (0001459839) (Subject)

      11/8/24 12:14:44 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • SI-BONE To Present at BofA Securities 2025 Healthcare Conference on May 13, 2025

      SANTA CLARA, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming 2025 BofA Securities Healthcare Conference in Las Vegas. Management will be hosting a fireside chat on Tuesday, May 13, 2025, at 8:40 a.m. Pacific Time/11:40 a.m. Eastern Time. Investors interested in listening to the conference call may do so by registering at this link: https://bofa.veracast.com/webcasts/bofa/healthcare2025/id92Nrrn.cfm. Live audio of the webcast will be available on the "Investors" section of the company's website at: www.si-bone.com. The webcast wil

      5/6/25 4:09:00 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • SI-BONE, Inc. Reports Financial Results for the First Quarter 2025 and Updates 2025 Guidance

      First Quarter 2025 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $47.3 million, representing growth of 24.9%U.S. revenue of $44.8 million, representing growth of 26.6%Gross margin of 79.7%, representing an improvement of 80 basis pointsNet loss of $6.5 million, representing an improvement of 40.0%Positive adjusted EBITDA of $0.5 million$144.4 million in cash and equivalents, with net cash usage in the quarter declining 31.7% to $5.6 million Recent Operational Highlights (any comparisons are to the prior year period) Over 1,400 active U.S. physicians with 300 physicians

      5/5/25 4:09:00 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • SI-BONE To Report First Quarter 2025 Financial Results on May 5, 2025

      SANTA CLARA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the first quarter of 2025 after market close on Monday, May 5, 2025. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by registering at this link: https://edge.media-server.com/mmc/p/ueassh6s. Live audio of the webcast will be available on the "Investors" section of the company's website at: www.si-bone.com. The webcast will be archived and available for replay for a

      4/14/25 4:09:00 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care

    $SIBN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Maheshwari Anshul sold $93,926 worth of shares (4,937 units at $19.02), decreasing direct ownership by 2% to 232,069 units (SEC Form 4)

      4 - SI-BONE, Inc. (0001459839) (Issuer)

      5/14/25 8:33:42 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • Chief Executive Officer Francis Laura sold $661,368 worth of shares (38,504 units at $17.18) (SEC Form 4)

      4 - SI-BONE, Inc. (0001459839) (Issuer)

      5/9/25 7:01:42 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • Chief Financial Officer Maheshwari Anshul sold $599,033 worth of shares (33,287 units at $18.00), decreasing direct ownership by 12% to 237,006 units (SEC Form 4)

      4 - SI-BONE, Inc. (0001459839) (Issuer)

      5/9/25 7:00:36 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care

    $SIBN
    SEC Filings

    See more
    • SEC Form 144 filed by SI-BONE Inc.

      144 - SI-BONE, Inc. (0001459839) (Subject)

      5/16/25 4:21:18 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by SI-BONE Inc.

      SCHEDULE 13G/A - SI-BONE, Inc. (0001459839) (Subject)

      5/15/25 8:10:02 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by SI-BONE Inc.

      SCHEDULE 13G/A - SI-BONE, Inc. (0001459839) (Subject)

      5/15/25 10:56:51 AM ET
      $SIBN
      Medical/Dental Instruments
      Health Care